14 Feb 2018
// BUSINESSWIRE
https://www.businesswire.com/news/home/20180213006757/en/FDA-Grants-Priority-Review-Genentech%E2%80%99s-Rituxan-Rituximab/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==
LOOKING FOR A SUPPLIER?